Breast cancer targeted/ therapeutic with double and triple fusion Immunotoxins
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 200, 105651
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Immunotoxins: The Role of the ToxinToxins, 2013
- Efficiency of Immunotoxin Cytotoxicity Is Modulated by the Intracellular ItineraryPLOS ONE, 2012
- Therapeutic potential of anticancer immunotoxinsDrug Discovery Today, 2011
- Convergent Potency of Internalized Gelonin Immunotoxins across Varied Cell Lines, Antigens, and Targeting MoietiesJournal of Biological Chemistry, 2011
- Construction and Characterization of Novel, Recombinant Immunotoxins Targeting the Her2/neu Oncogene Product: In vitro and In vivo StudiesCancer Research, 2009
- A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityBlood, 2009
- Differential Cellular Internalization of Anti-CD19 and -CD22 Immunotoxins Results in Different Cytotoxic ActivityCancer Research, 2008
- ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expressionCellular Microbiology, 2008
- Use of bacteria as anticancer agentsExpert Opinion on Biological Therapy, 2001
- Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coliCell, 1987